Bristol Myers acquires cell therapy partner 2seventy bio
In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other Friday’s ...
Bristol-Myers Squibb has won FDA approval for the first ... ballpark as the Opdivo/Yervoy combination for melanoma. BMS sues AZ, claiming Imfinzi infringes Opdivo patents BMS, meanwhile, has ...
The stock's fall snapped a four-day winning streak.
In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best dividend stocks to buy according to billionaires. Dividend stocks have been ...
Bristol-Myers Squibb (NYSE:BMY – Get Free Report)’s stock price hit a new 52-week high during trading on Friday .The stock traded as high as $61.68 and last traded at $61.90, with a volume of ...
Bristol Myers Squibb stock (NYSE: BMY) has gained 7% this year, outperforming the S&P 500 which has declined 1%. BMS’s strong Q4 performance has helped drive its positive momentum. While markets ...
In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best drug stocks to buy now. Large American pharmaceutical companies are showing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback